Sign in
4

Changes in Ownership

Edwards Lifesciences Corp Filed Acc 0001225208-25-007321

Global President TAVR & Surg sold 8,950 shares at $78.06 ($698,679)

  • Global President TAVR & Surg acquired 8,950 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Wood Larry L · Global President TAVR & Surg

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2025-08-18 Exercise or conversion : show line 1 in the form 10b5-1 +8,950 $59.26 $530,347 215,850.39 D
2025-08-18 Sale : show line 2 in the form 10b5-1 −8,950 $78.06 $698,679 206,900.39 D
Open-market sales · 8,950 sh · avg $78.06 · $698,679

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2025-08-18 Exercise or conversion : show line 3 in the form 10b5-1 Employee Stock Option (Right to Acquire) −8,950 35,800 D
Loading xslF345X05/doc4.xml…